Vitalhub Corp. (VHI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

O'Brien Goffenberg. After our prepared remarks, we will open up the line to questions from analysts. Please press star 1 or use the raise hand function to indicate that you would like to ask a question. Before we begin, I will read our cautionary note regarding forward-looking information. Certain information to be discussed during this call contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, please review the forward-looking statements disclosure in the earnings press release and in our CDAR filings. As well, our commentary today will include adjusted financial measures, which are non-IFRS measures. These should be considered as a supplement to and not a substitute for IFRS measures. Reconciliations between the two can be found in our CDAR filings. With that, I'll hand the call over to Brian to go over financial highlights for the quarter. Over to you, Brian. Thank you, Christian. Good morning, everyone, and thank you for joining the call today. We are pleased to report the results for the second quarter of 2026. Vitalab reached a new milestone this quarter, exceeding $100 million of annual recurring revenue. We closed June at $101.5 million, representing 10% organic growth over the prior year. Adjusted EBITDA margin continued to increase sequentially at 26% in the second quarter. Some of the key financial highlights for the quarter are as follows. We report a total revenue of $31.7 million, an increase of 33% year over year. Recurring revenue or term license maintenance and support segment was $24.5 million or 77% of total revenue. Virtual care term license revenue was $2.3 million. Perpetual license revenue was $800...